Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513162-22-000122
Filing Date
2022-10-13
Accepted
2022-10-13 16:12:20
Documents
45
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmra-20220831.htm   iXBRL 10-Q 781472
2 EXHIBIT 3.1 exhibit3_1.htm EX-3.1 86188
3 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 8219
4 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 8973
5 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 4322
6 EXHIBIT 32.2 exhibit32_2.htm EX-32.2 4406
  Complete submission text file 0001513162-22-000122.txt   3795141

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmra-20220831.xsd EX-101.SCH 33683
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmra-20220831_cal.xml EX-101.CAL 33794
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmra-20220831_def.xml EX-101.DEF 169799
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bmra-20220831_lab.xml EX-101.LAB 319290
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmra-20220831_pre.xml EX-101.PRE 177330
39 EXTRACTED XBRL INSTANCE DOCUMENT bmra-20220831_htm.xml XML 418643
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9496452111
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-37863 | Film No.: 221309196
SIC: 2835 In Vitro & In Vivo Diagnostic Substances